688580 伟思医疗
已收盘 12-26 15:00:00
资讯
新帖
简况
【机构调研记录】华安基金调研伟思医疗
证券之星 · 12-26 08:10
【机构调研记录】华安基金调研伟思医疗
12月25日伟思医疗涨5.73%,北信瑞丰健康生活基金重仓该股
证券之星 · 12-25 15:35
12月25日伟思医疗涨5.73%,北信瑞丰健康生活基金重仓该股
伟思医疗涨5.73%,华安证券二个月前给出“买入”评级
证券之星 · 12-25 15:34
伟思医疗涨5.73%,华安证券二个月前给出“买入”评级
长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证
21世纪经济报道 · 12-23
长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证
伟思医疗(688580.SH)拟1.19亿元出售南京市雨花台区房屋建筑物及附属设施
智通财经 · 12-22
伟思医疗(688580.SH)拟1.19亿元出售南京市雨花台区房屋建筑物及附属设施
伟思医疗(688580)披露部分募投项目结项并将节余募集资金永久补充流动资金,12月17日股价上涨1.87%
证券之星 · 12-17
伟思医疗(688580)披露部分募投项目结项并将节余募集资金永久补充流动资金,12月17日股价上涨1.87%
11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股
证券之星 · 11-21
11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股
每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划
证券之星 · 11-16
每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划
伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%
证券之星 · 11-12
伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%
每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动
证券之星 · 11-09
每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动
11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元
证券之星 · 11-07
11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元
【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)
证券之星 · 10-29
【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)
伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长
证券之星 · 10-24
伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%
智通财经 · 10-22
伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%
每周股票复盘:伟思医疗(688580)取消监事会并补选独董
证券之星 · 09-21
每周股票复盘:伟思医疗(688580)取消监事会并补选独董
每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元
证券之星 · 09-07
每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元
【机构调研记录】金元顺安基金调研伟思医疗
证券之星 · 09-03
【机构调研记录】金元顺安基金调研伟思医疗
伟思医疗:9月1日高管陈莉莉减持股份合计3200股
证券之星 · 09-02
伟思医疗:9月1日高管陈莉莉减持股份合计3200股
每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%
证券之星 · 08-31
每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%
伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%
证券之星 · 08-28
伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%
加载更多
公司概况
公司名称:
南京伟思医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-07-21
主营业务:
南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。
发行价格:
67.58
{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":48.07,"timestamp":1766732400000,"preClose":49.28,"halted":0,"volume":2091846,"delay":0,"changeRate":-0.0246,"floatShares":95771299,"shares":95771299,"eps":1.3152,"marketStatus":"已收盘","change":-1.21,"latestTime":"12-26 15:00:00","open":49.45,"high":49.45,"low":47.91,"amount":101000000,"amplitude":0.0313,"askPrice":48.09,"askSize":22,"bidPrice":48.07,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.3152,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":49.28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":54.21,"lowLimit":44.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95771288,"isCdr":false,"pbRate":2.78,"roa":"--","peRate":36.549574,"roe":"6.17%","epsLYR":1.0685,"committee":0.439394,"marketValue":4604000000,"turnoverRate":0.0218,"status":1,"afterMarket":{"amount":0,"volume":0,"close":48.07,"buyVolume":0,"sellVolume":0,"time":1766734437768,"indexStatus":"已收盘 12-26 15:30:00","preClose":49.28},"floatMarketCap":4604000000},"requestUrl":"/m/hq/s/688580","defaultTab":"news","newsList":[{"id":"2594071254","title":"【机构调研记录】华安基金调研伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2594071254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594071254?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:10","pubTimestamp":1766707819,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为华安中证有色金属矿业主题指数发起式A,最新单位净值为1.83,近一年增长88.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600003573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2594097280","title":"12月25日伟思医疗涨5.73%,北信瑞丰健康生活基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594097280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594097280?lang=zh_cn&edition=full","pubTime":"2025-12-25 15:35","pubTimestamp":1766648100,"startTime":"0","endTime":"0","summary":"证券之星消息,12月25日伟思医疗涨5.73%,收盘报49.28元,换手率3.5%,成交量3.35万手,成交额1.63亿元。重仓伟思医疗的公募基金请见下表:该股最近90天内共有7家机构给出评级,买入评级4家,增持评级3家;过去90天内机构目标均价为60.0。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为华银基金的北信瑞丰健康生活。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500017100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2594800262","title":"伟思医疗涨5.73%,华安证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2594800262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594800262?lang=zh_cn&edition=full","pubTime":"2025-12-25 15:34","pubTimestamp":1766648093,"startTime":"0","endTime":"0","summary":"今日伟思医疗涨5.73%,收盘报49.28元。2025年10月24日,华安证券研究员谭国超,李婵发布了对伟思医疗的研报《2025Q3业绩增长稳健,深化脑机领域布局》,该研报对伟思医疗给出“买入”评级。2025-2027年的EPS分别为1.40元、1.67元和2.01元,对应PE估值分别为33x、28x和23x,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为43.28%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西部证券的李雯。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500017097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","600909"],"gpt_icon":0},{"id":"2593645198","title":"长护险将逐步覆盖所有参保人;减重版司美格鲁肽国内获批新适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645198","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593645198?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:10","pubTimestamp":1766448612,"startTime":"0","endTime":"0","summary":"政策动向国家医保局:“十五五”时期长期护理保险制度将从试点转向全面建制12月22日,在2025全国长期护理保险高质量发展大会上,国家医保局党组书记、局长章轲在致辞时表示,经过试点,长期护理保险制度覆盖近3亿人,累计惠及超330万失能群众,基金支出超千亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233598873113.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233598873113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000165453.HKD","LU1951186391.HKD","LU0314109678.HKD","LU0326950275.SGD","BK1191","603439","BK1515","BK0046","LU1993786604.SGD","IE00BZ08YS42.EUR","002086","IE0008369823.USD","LU1328277881.USD","PCT","IE0008368742.USD","LU0072913022.USD","IE00B543WZ88.USD","LU0140636845.USD","IE00BZ08YT58.USD","LU1226287529.USD","BK0251","01093","LU1152091168.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU0067412154.USD","LU0501845795.SGD","LU0315179316.USD","BK4090","002873","LU1226287875.USD","LU1226287792.SGD","LU1807302812.USD","BK1521","LU1813983027.USD","SG9999004220.SGD","LU0880133367.SGD","688580","LU1152091754.HKD","LU1960683339.HKD","IE00B5MMRT66.SGD","LU1226288253.USD","LU1008478684.HKD","BK0239","BK0092","LU1226288170.HKD","BK0213","LU2039709279.SGD"],"gpt_icon":0},{"id":"2593885084","title":"伟思医疗(688580.SH)拟1.19亿元出售南京市雨花台区房屋建筑物及附属设施","url":"https://stock-news.laohu8.com/highlight/detail?id=2593885084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593885084?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:50","pubTimestamp":1766393433,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)发布公告,为优化资产结构、提升资源配置效率并增强资金流动性,公司拟处置现总部资产—位于南京市雨花台区宁双路19号9幢的房屋建筑物及附属设施。经与交易方江苏云智汇创业投资有限公司协商一致,确定含税转让总价为1.19亿元。本次处置有助于盘活存量资产,解决搬迁后的闲置问题,降低运维成本,并回笼资金用于新总部运营及核心业务发展,符合公司长期战略和全体股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2592154959","title":"伟思医疗(688580)披露部分募投项目结项并将节余募集资金永久补充流动资金,12月17日股价上涨1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592154959","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592154959?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:25","pubTimestamp":1765981504,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘,伟思医疗报收于44.72元,较前一交易日上涨1.87%,最新总市值为42.83亿元。近日,南京伟思医疗科技股份有限公司发布公告称,公司决定将首次公开发行股票募投项目中的“康复设备组装调试项目”和“信息化建设项目”结项,两个项目节余募集资金合计3,697.74万元。公司拟将节余资金永久补充流动资金,用于日常经营与业务发展,并注销相关募集资金专户。该事项已经董事会审议通过,保荐机构无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700039782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2585419085","title":"11月21日伟思医疗跌5.37%,北信瑞丰健康生活基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585419085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585419085?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:48","pubTimestamp":1763711331,"startTime":"0","endTime":"0","summary":"证券之星消息,11月21日伟思医疗跌5.37%,收盘报43.34元,换手率1.44%,成交量1.38万手,成交额6104.38万元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为华银基金的北信瑞丰健康生活。北信瑞丰健康生活目前规模为0.9亿元,最新净值1.155,较上一交易日下跌0.94%,近一年上涨8.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2583965492","title":"每周股票复盘:伟思医疗(688580)股东减持117.68万股未完成原计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2583965492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583965492?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:49","pubTimestamp":1763239747,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,伟思医疗报收于47.9元,较上周的49.22元下跌2.68%。本周关注点股本股东变化:股东南京志达创业投资中心减持117.68万股,占总股本1.2287%。股本股东变化股东增减持11月12日伟思医疗发布公告,股东南京志达创业投资中心于2025年11月5日至11月11日间合计减持44.86万股,占公司目前总股本的0.4684%,变动期间该股股价下跌7.58%,截止11月11日收盘报48.17元。本次实际减持情况与此前披露的计划一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2582771093","title":"伟思医疗(688580)披露股东减持股份计划时间届满暨减持结果公告,11月12日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582771093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582771093?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:25","pubTimestamp":1762957524,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,伟思医疗报收于48.2元,较前一交易日上涨0.06%,最新总市值为46.16亿元。该股当日开盘48.3元,最高49.49元,最低47.93元,成交额达9160.83万元,换手率为1.97%。本次减持计划时间区间已届满,未完成原定减持计划,当前持股比例由8.29%降至7.06%。本次实际减持情况与此前披露的计划一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2582869509","title":"每周股票复盘:伟思医疗(688580)股东减持72.82万股触及1%变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2582869509","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582869509?lang=zh_cn&edition=full","pubTime":"2025-11-09 02:34","pubTimestamp":1762626855,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,伟思医疗报收于49.22元,较上周的54.13元下跌9.07%。来自公司公告汇总:控股股东及其一致行动人合计持股比例由47.74%降至46.98%。交易信息汇总11月7日伟思医疗发生3笔大宗交易,成交金额993.29万元。股本股东变化股东增减持11月4日伟思医疗发布公告,股东南京志达创业投资中心于2025年8月14日至2025年11月4日间合计减持72.82万股,占公司目前总股本的0.7604%,变动期间该股股价下跌6.93%,截止11月4日收盘报52.12元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2581008419","title":"11月7日伟思医疗发生3笔大宗交易 成交金额993.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581008419?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:21","pubTimestamp":1762507272,"startTime":"0","endTime":"0","summary":"证券之星消息,11月7日伟思医疗发生大宗交易,交易数据如下:近三个月该股共发生3笔大宗交易,合计成交2207.0手,折价成交3笔。该股近期无解禁股上市。截至2025年11月7日收盘,伟思医疗报收于49.22元,下跌2.46%,换手率1.62%,成交量1.55万手,成交额7717.03万元。该股近半年内有股东持股变动,合计净减持72.82万股,股东增减持明细如下表:该股最近90天内共有7家机构给出评级,买入评级5家,增持评级2家;过去90天内机构目标均价为60.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700027549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2579291463","title":"【机构调研记录】汇泉基金调研伟思医疗、雷迪克等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579291463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579291463?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:06","pubTimestamp":1761696388,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,汇泉基金近期对3家上市公司进行了调研,相关名单如下:1)伟思医疗 个股亮点:公司的下肢外骨骼装置进入医保目录;公司电刺激类产品,主要包括 MyOnyx 生物刺激反馈仪、瑞翼生物刺激反馈仪等,主要应用于妇产相关科室2)雷迪克 调研纪要:截至2025年第三季度末,公司营收达80,543.94万元,同比增长56.52%;净利润13,765.78万元,同比增长48.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900012533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0264","688580","300652"],"gpt_icon":0},{"id":"2577588537","title":"伟思医疗(688580)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2577588537","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577588537?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:03","pubTimestamp":1761256982,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期伟思医疗发布2025年三季报。根据财报显示,伟思医疗营收净利润同比双双增长。截至本报告期末,公司营业总收入3.26亿元,同比上升11.58%,归母净利润1.02亿元,同比上升30.68%。按单季度数据看,第三季度营业总收入1.15亿元,同比上升14.87%,第三季度归母净利润3282.4万元,同比上升14.99%。去年的净利率为25.49%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580"],"gpt_icon":0},{"id":"2577666352","title":"伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577666352","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577666352?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:31","pubTimestamp":1761125460,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)披露2025年第三季度报告,公司前三季度实现营收3.26亿元,同比增长11.58%;归属于上市公司股东的净利润1.02亿元,同比增长30.68%;扣非净利润9360万元,同比增长37.35%;基本每股收益1.07元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"伟思医疗(688580.SH)发布前三季度业绩,归母净利润1.02亿元,同比增长30.68%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580"],"gpt_icon":0},{"id":"2569246317","title":"每周股票复盘:伟思医疗(688580)取消监事会并补选独董","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246317","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246317?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:01","pubTimestamp":1758398479,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,伟思医疗报收于49.55元,较上周的50.88元下跌2.61%。本周,伟思医疗9月18日盘中最高价报52.98元。本周关注点公司公告汇总:伟思医疗召开2025年第一次临时股东大会,审议通过取消监事会、修订公司章程等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2565546881","title":"每周股票复盘:伟思医疗(688580)陈莉莉减持7600股,成交额40.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546881?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:07","pubTimestamp":1757200032,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,伟思医疗报收于51.6元,较上周的52.96元下跌2.57%。本周,伟思医疗9月1日盘中最高价报53.79元。本周关注点股本股东变化:董事陈莉莉减持3200股,占总股本0.0033%。公司公告汇总:陈莉莉减持7600股,成交额40.06万元,持股降至23025股。陈莉莉减持前持有30,625股,通过集中竞价减持7,600股,价格区间为48.40~53.46元/股,减持金额400,620.80元,当前持股23,025股。减持期间为2025年6月3日至9月3日,实际减持与披露计划一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2564334597","title":"【机构调研记录】金元顺安基金调研伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2564334597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564334597?lang=zh_cn&edition=full","pubTime":"2025-09-03 08:03","pubTimestamp":1756857818,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为金元顺安产业臻选混合A,最新单位净值为0.9,近一年增长63.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300005647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2564385802","title":"伟思医疗:9月1日高管陈莉莉减持股份合计3200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564385802","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564385802?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:04","pubTimestamp":1756814662,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月2日市场公开信息、上市公司公告及交易所披露数据整理,伟思医疗最新董监高及相关人员股份变动情况:2025年9月1日公司董事,高级管理人员陈莉莉共减持公司股份3200.0股,占公司总股本为0.0033%。变动期间公司股价上涨1.17%,9月1日当日收盘报53.58元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200036002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2563383640","title":"每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563383640","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563383640?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:29","pubTimestamp":1756607348,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,伟思医疗报收于52.96元,较上周的54.72元下跌3.22%。本周,伟思医疗8月26日盘中最高价报56.56元。业绩披露要点:2025年中报归母净利润6932.42万元,同比上升39.71%。股本股东变化股东户数变动截至2025年6月30日,伟思医疗股东户数为8095.0户,较3月31日增加2162.0户,增幅36.44%。2025年第二季度单季度主营收入1.15亿元,同比上升10.23%;单季度归母净利润3610.42万元,同比上升29.56%;单季度扣非净利润3303.3万元,同比上升36.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2562082607","title":"伟思医疗(688580)6月30日股东户数0.81万户,较上期增加36.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562082607","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562082607?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:28","pubTimestamp":1756373314,"startTime":"0","endTime":"0","summary":"在医疗器械行业个股中,伟思医疗股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.21万户。从股价来看,2025年3月31日至2025年6月30日,伟思医疗区间涨幅为39.47%,在此期间股东户数增加2162.0户,增幅为36.44%。根据统计,伟思医疗2025年3月31日至2025年6月30日,主力资金净流出1.87亿元,游资资金净流入1.4亿元,散户资金净流入4792.44万元。期间龙虎榜该股共上榜4次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800033226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766842147022,"stockEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.0778},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.0834},{"period":"1year","weight":0.6197},{"period":"ytd","weight":0.7527}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"8098人(较上一季度增加0.04%)","perCapita":"11826股","listingDate":"2020-07-21","address":"江苏省南京市雨花台区宁双路19号9栋","registeredCapital":"9577万元","survey":" 南京伟思医疗科技股份有限公司的主营业务是医疗器械的研发、生产和销售。公司的主要产品是经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、VisheeNEO生物刺激反馈仪、MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、多参数生物反馈仪、团体生物反馈仪、新生儿脑电测量仪、高频电灼仪、Nd:YAG倍频皮秒激光治疗仪和科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、高频电极、治疗激光用石英光纤和一次性医用激光光纤。","listedPrice":67.58},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}